Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Greenberg

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Annals of Neurology|July 25, 2024
Smouldering-Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future DirectionsAntonio Scalfari, Anthony Traboulsee, Jiwon Oh, et al.
Trials|December 19, 2024
The NExT trial: Protocol for a two-phase randomized controlled trial testing transcranial magnetic stimulation to augment exposure therapy for youth with OCDChristine Conelea, Claire Breitenfeldt, Alixandra Wilens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2023
VH2+ Antigen-Experienced B Cells in the Cerebrospinal Fluid Are Expanded and Enriched in Pediatric Anti-NMDA Receptor EncephalitisNancy Monson, Chad Smith, Hannah Greenberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2022
Aptamer-Based Screen of Neuropsychiatric Lupus Cerebrospinal Fluid Reveals Potential Biomarkers That Overlap With the Choroid Plexus TranscriptomeKamala Vanarsa, Prashanth Sasidharan, Valeria Duran, et al.
Therapeutic Advances in Neurological Disorders|June 23, 2011
Symptomatic therapy in multiple sclerosisTeresa C Frohman, Wanda Castro, Anjali Shah, et al.
The New England Journal of Medicine|September 13, 2018
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple SclerosisTanuja Chitnis, Douglas L Arnold, Brenda Banwell, et al.
Iscience|September 12, 2022
CLN7/MFSD8 may be an important factor for SARS-CoV-2 cell entryElena-Sofia Heinl, Sebastian Lorenz, Barbara Schmidt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 8, 2020
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIG<i>MS</i> studyTanuja Chitnis, Brenda Banwell, Lauren Krupp, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
A novel frameshift mutation in Phosphoinositide 3-kinase regulatory subunit 1 (<i>PIK3R1</i>) causes immunodeficiency and Amyotrophic Lateral Sclerosis (ALS)Brice Calco, Colin L Sweeney, Joseph Steiner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 1, 2021
CSF-Derived CD4<sup>+</sup> T-Cell Diversity Is Reduced in Patients With Alzheimer Clinical SyndromeChaitanya Joshi, Karthigayini Sivaprakasam, Scott Christley, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Annals of Neurology|July 25, 2024
Smouldering-Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future DirectionsAntonio Scalfari, Anthony Traboulsee, Jiwon Oh, et al.
Trials|December 19, 2024
The NExT trial: Protocol for a two-phase randomized controlled trial testing transcranial magnetic stimulation to augment exposure therapy for youth with OCDChristine Conelea, Claire Breitenfeldt, Alixandra Wilens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2023
VH2+ Antigen-Experienced B Cells in the Cerebrospinal Fluid Are Expanded and Enriched in Pediatric Anti-NMDA Receptor EncephalitisNancy Monson, Chad Smith, Hannah Greenberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 31, 2022
Aptamer-Based Screen of Neuropsychiatric Lupus Cerebrospinal Fluid Reveals Potential Biomarkers That Overlap With the Choroid Plexus TranscriptomeKamala Vanarsa, Prashanth Sasidharan, Valeria Duran, et al.
Therapeutic Advances in Neurological Disorders|June 23, 2011
Symptomatic therapy in multiple sclerosisTeresa C Frohman, Wanda Castro, Anjali Shah, et al.
The New England Journal of Medicine|September 13, 2018
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple SclerosisTanuja Chitnis, Douglas L Arnold, Brenda Banwell, et al.
Iscience|September 12, 2022
CLN7/MFSD8 may be an important factor for SARS-CoV-2 cell entryElena-Sofia Heinl, Sebastian Lorenz, Barbara Schmidt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 8, 2020
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIG<i>MS</i> studyTanuja Chitnis, Brenda Banwell, Lauren Krupp, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
A novel frameshift mutation in Phosphoinositide 3-kinase regulatory subunit 1 (<i>PIK3R1</i>) causes immunodeficiency and Amyotrophic Lateral Sclerosis (ALS)Brice Calco, Colin L Sweeney, Joseph Steiner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 1, 2021
CSF-Derived CD4<sup>+</sup> T-Cell Diversity Is Reduced in Patients With Alzheimer Clinical SyndromeChaitanya Joshi, Karthigayini Sivaprakasam, Scott Christley, et al.
Pageof 10